Robert J. Snyder, MD, PhD, DPM, FACFAS, CWS-P, MBA, MSc, FFPM, RCPS(Glasg)

Dear Drs Melin and Dean: Thank you for your feedback and appreciation toward the publication of our July 2020 article with Wounds1 in your November 2020 Letter to the Editor.2 It was our goal to bring to light the different types of...

Dear Drs Melin and...

12/07/2020

Wounds

Diagnostic Dilemmas

Mixed Etiology Hydroxyurea-Related Lower Leg Ulcer that Masqueraded as Sequelae From Sickle Cell Disease and Venous Insufficiency

09/01/2012

Mina Abadeer ;

Wajdi Nassier ;

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Hani M. Badahdah ;

Clifford O'Connor ;

Zahra Karbasian ;

09/01/2012

Wounds

Original Research

Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study

07/02/2018

Keyur Patel ;

Maria A. Kasper ;

Igal Kushnir ;

Marissa J. Carter , PhD;

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Alon Kushnir ;

This pilot study evaluates safety in terms of the occurrence of adverse events (AEs) as well as the efficacy in terms of complete wound healing rates of a blood clot product when applied to chronic neuropathic diabetic foot ulcers (DFUs).

This pilot study evaluates...

07/02/2018

Wounds

Videos

Promising Results of Bromelain-based Enzymatic Debridement

10/06/2022

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

In this research presentation, Dr. Robert J. Snyder reports on the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm and microbial loads in...

In this research presentation,...

10/06/2022

Wounds

Videos

Next Steps in Studying Bromelain-based Enzymatic Debridement on Biofilm and Microbial Loads

10/06/2022

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

In this interview, Dr. Robert J. Snyder provides insight into future plans to further the results of an open phase 2 study assessing the safety, efficacy, and pharmacologic effects of bromelain-based enzymatic debridement product on biofilm...

In this interview, Dr. Robert J....

10/06/2022

Wounds

Results from an Ongoing Open Phase 2 Study Assessing the Safety, Efficacy and Pharmacological Effects of Bromelain-based Enzymatic Debridement on Biofilm, Microbial loads and Cytokines in patients with DFU and VLU

IntroductionDebridement represents a key step in the management of chronic wounds and is considered a basic necessity to induce tissue repair. Biofilm infection in wounds is a major contr...

Caroline S. Gwaltney , PT, DPT, CWS;

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Lisa Borrero , PhD, FAGHE;

Laura Santurri , PhD, MPH, CPH;

05/26/2022